Comorbidities are common in patients with COPD

May 21, 2012, American Thoracic Society

The majority of patients with chronic obstructive pulmonary disease (COPD) referred for pulmonary rehabilitation have multiple extra-pulmonary comorbidities, according to a new study from the Netherlands.

"Comorbidities were common in our sample of 213 COPD patients from the CIRO Comorbidity (CIROCO) study, and most patients had varying combinations of comorbidities," said Lowie Vanfleteren, MD, of CIRO+, a center of expertise in chronic organ failure in Horn, the Netherlands, which is connected to the Maastricht University Medical Center. "The presence of these comorbidities may complicate the management of these patients and may ultimately influence their prognosis."

The results of the study will be presented at the ATS 2012 International Conference in San Francisco. Comorbidities were objectively assessed by measuring triglycerides, , hemoglobin, glucose, resting systolic and diastolic blood pressure, renal function (using estimated ), arterial stiffness (using aortic pulse wave velocity), subclinical atherosclerosis (using carotid intima-media thickness); (using DXA scans of the hip and lumbar spine), body weight, fat-free mass (using electrical bio impedance), and symptoms of anxiety and depression (using the Hospital rating scale). Abnormal values were defined based on well-established cut-offs. The most common comorbidities observed were hyperglycemia (54%), subclinical atherosclerosis (53%), hypertension (48%), dyslipidemia (36%) and osteoporosis (31%). Obesity (23%), underweight (14%), muscle wasting (28%), renal impairment (22%), anxiety (21%) and depression (16%) were also present in a substantial percentage of patients.

Almost all (98%) patients had two or more comorbidities, and 54% had four or more. Using data mining software, five unique groups of patients with different combinations of comorbidities were identified.

"Identifying patients with particular clusters of comorbidities may ultimately lead to the development of patient-tailored treatment," said Dr. Vanfleteren.

"Most previous studies of comorbidities in COPD patients have used self-report data, limiting their validity, and have only examined comorbidities individually," said Dr. Vanfleteren. "By using objective measures of a range of comorbidities in our study, we have shown that not only are comorbidities common in COPD patients, but they often occur in groups."

"Future COPD practice guidelines should specifically address the treatment of comorbidities in these patients," Dr. Vanfletern concluded.

Explore further: Comorbidities increase risk of mortality in COPD patients

More information: "Objectified Co-Morbidities In Patients With COPD: The CIROCO Study" (Session B97, Monday, May 21, Room 3020-3022, Moscone Center; Abstract 30329)

Related Stories

Comorbidities increase risk of mortality in COPD patients

May 4, 2012
Comorbidities are common among patients with chronic obstructive pulmonary disease (COPD), and a number of these comorbidities are independently associated with an increased mortality risk, according to a new study.

Worse outcomes for older breast cancer patients with other health problems

June 30, 2011
Older breast cancer patients with certain other health problems have higher mortality rates than patients without these problems according to a study published online June 30 in the Journal of the National Cancer Institute. ...

Is anesthesia dangerous?

July 21, 2011
In pure numerical terms, anesthesia-associated mortality has risen again. The reasons for this are the disproportionate increase in the numbers of older and multimorbid patients and surgical procedures that would have been ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.